For a multi-location optometry group, AI is not a purchase category. It is a decision about which patient-access and back-office workflows should be made more consistent, faster to complete, or easier to manage across locations. The technology is useful only when it improves a defined operating problem without creating new risk, rework, or reporting gaps.
The original case for AI in healthcare included a large estimate of potential administrative savings. A 2023 report covered by Healthcare Dive discussed a possible $360 billion annual opportunity across the industry. That figure is not a business case for an individual organization. A group should make its decision from its own call patterns, scheduling capacity, exception volume, staffing model, and ability to govern the new workflow.
For eye-care operators, the practical opportunities are usually operational rather than clinical: classifying inbound requests, preparing appointment information, identifying incomplete intake, routing routine follow-up, summarizing queue activity, and surfacing work that needs a person. Those tasks sit close to the patient-access system. They should be evaluated with the same discipline used for optometry operations: clear ownership, documented exceptions, quality review, and a reliable system of record.
Table of Contents
- What Problem Should AI Solve First?
- Which AI Uses Are Practical for Optometry Groups?
- When Does AI Improve Scheduling Rather Than Add Work?
- How Should Leaders Calculate the Cost of an AI Investment?
- Is Your Group Ready to Use AI in Patient Access?
- What Governance Is Required Before AI Touches Patient Workflows?
- Should You Buy Software, Build Internally, or Use a Managed Partner?
- How Should a Group Pilot AI Without Disrupting Access?
- What Is the Right Decision Framework for Executives?
What Problem Should AI Solve First?
Start with a workflow that already has a visible failure mode. A group may have missed calls during peak hours, appointment requests that wait too long for a callback, inconsistent insurance-verification notes, or managers who cannot see where an intake request stalled. Those are operating problems. AI may be part of the response, but it is not the starting point.
Choose one workflow and state the outcome in measurable language. For example: every appointment request receives a documented next step; the central team can identify requests missing required information; or locations use the same reason codes for scheduling exceptions. A vague goal such as “use AI to improve the front desk” cannot be evaluated, trained, or governed.
The workflow map should show the trigger, the person or team that owns the next action, the system where the work is recorded, the decisions that require judgment, and the final status. This is especially important for groups that have grown through acquisition. An AI tool trained on five different location habits will repeat inconsistency at a larger scale. The first job is to define what should be consistent and what should remain a location-approved exception.
The operating maturity work described in this optometry efficiency framework is a useful prerequisite. If leadership cannot tell whether a request was completed correctly, it cannot tell whether automation improved it.
Which AI Uses Are Practical for Optometry Groups?
The strongest early use cases assist staff with repeatable administrative work and preserve human review for exceptions. They do not make clinical determinations or replace the office’s responsibility for patient communication. In optometry, these applications often fall into four categories.
First, AI can support intake and request classification. A tool may identify whether an inbound message appears to concern an exam appointment, a contact-lens reorder, an insurance question, a prescription request, or a general location inquiry. The value is not the label itself. It is getting the request into the correct queue with enough context for the next person to act. The clinical-retail routing requirements in the optometry intake guide show why a generic “appointment” category is often too broad for an eye-care group.
Second, AI can prepare work for a scheduler or patient-access representative. It can assemble information already present in approved systems, identify fields that need verification, or suggest the appropriate checklist for a standard request. The representative still confirms the information, follows the group’s scripts, and documents the outcome. This reduces searching and duplicate entry without giving the tool authority to make an exception.
Third, AI can help operations leaders review patterns across locations. It may summarize recurring callback reasons, group common scheduling exceptions, or flag a rising volume of incomplete intake items. Leaders should treat these outputs as prompts for investigation, not as final findings. A summary can point to a training gap, a template problem, or a capacity issue, but it cannot establish the cause on its own.
Fourth, AI can contribute to back-office prioritization, such as organizing non-clinical documents, drafting internal workflow notes, or identifying repetitive tasks that need a standard process. The benefit comes from reducing avoidable administrative handling, not from automating every decision. The American Optometric Association includes scheduling, billing, recordkeeping, and office procedures among day-to-day operational responsibilities, which is why these are appropriate areas to examine before considering higher-risk uses.
When Does AI Improve Scheduling Rather Than Add Work?
Scheduling is a common first target because it is high volume and directly visible to patients. Yet scheduling automation fails when the group has not defined appointment types, required intake information, provider constraints, escalation rules, and the difference between a completed booking and an unresolved request.
An AI-supported scheduling workflow can be useful when it does three things well: it captures the reason for the request, presents the right approved options, and hands off uncertain cases to a trained person. A patient asking for a routine eye exam, a caller asking about a contact-lens prescription, and a person with an insurance question should not be forced through the same path. The group must decide which details can be collected automatically and which require staff review before an appointment is confirmed.
Central scheduling guidance from MGMA reinforces the broader point that centralization requires process design, not merely a different place for calls to land. For a multi-location group, that means an AI assistant needs the same current scheduling rules, location directories, provider-template constraints, and escalation paths used by the human team. If those inputs are scattered across inboxes and personal notes, automation will expose the weakness rather than solve it.
Before selecting a tool, inspect a sample of real requests from several locations. Count how many follow a standard path, how many need a location-specific rule, and how many require judgment or clinical escalation. The standard requests may be candidates for assistance. The other categories should be routed deliberately, with no promise that a tool can resolve them on its own. For related operating measures, see patient-access metrics for healthcare executives.
How Should Leaders Calculate the Cost of an AI Investment?
An AI business case needs a total-cost view, not a subscription-price comparison. The direct costs are usually easy to see: software fees, integration work, implementation support, security review, training, and quality assurance. The less visible costs are often more consequential: time spent standardizing workflows, maintaining knowledge, reviewing exceptions, correcting inaccurate outputs, and supporting locations through the change.
On the benefit side, avoid turning every activity count into a financial claim. Track the operational measures that the tool is expected to affect. Depending on the use case, that may include callback aging, the share of requests with complete intake, time spent on repeat documentation, schedule-fill speed, rework volume, or variation between locations. Use a baseline from the group’s current operation. Then define what change would be meaningful enough to justify the cost and management attention.
A simple decision packet should include:
- The workflow and locations in scope.
- The current baseline, data source, and known data gaps.
- Total first-year and ongoing costs, including internal operating time.
- The expected operational change and the assumptions behind it.
- Risks, exception categories, human-review requirements, and a stop condition.
Run sensitivity checks before approving a rollout. What happens if adoption is uneven, if the integration takes longer than planned, or if the expected volume does not materialize? Does the investment still make sense if the tool only helps one request type? This is the same practical discipline used in a cost-benefit analysis of outsourced optometry operations: make assumptions visible and compare them with an alternative operating model.
Is Your Group Ready to Use AI in Patient Access?
Readiness is not a question of whether the group has an AI budget. It is a question of whether the organization can run the affected workflow consistently enough to evaluate a change. A group is more ready when it has an approved workflow owner, a usable source of truth for scheduling and intake rules, common definitions for key statuses, and a way to review a sample of completed work.
There are several warning signs that a group should stabilize the process first. If managers cannot agree on which appointment type applies, if callback ownership changes by location without documentation, or if staff keep crucial rules in personal notes, a technology purchase will likely create more exceptions. The right move may be to standardize the workflow, improve training, or create a shared knowledge source before adding automation.
Data readiness matters as well. The group should know which system is authoritative for appointment availability, patient-access notes, location information, and reporting. It should also identify what information the AI tool may access, what must remain outside its scope, and how data will be retained. In healthcare operations, the privacy and security review cannot be deferred until after the pilot begins.
Readiness also includes staffing. Someone must own the tool after launch, monitor performance, update approved content, review failures, and coordinate with locations. A pilot without an accountable operator becomes another application that offices work around. Groups assessing their service model can compare the roles of a virtual assistant and front-desk outsourcing partner before deciding whether the gap is software, managed capacity, or both.
What Governance Is Required Before AI Touches Patient Workflows?
The governance standard should match the task’s risk. Tools that draft an internal summary of non-sensitive operational data need a different review process than tools that interact with patients or use information from patient systems. Every implementation should specify the permitted use, prohibited use, human owner, escalation path, audit method, and process for removing access if the tool is no longer appropriate.
For patient-access work, keep a human in control of exceptions, unclear requests, urgent concerns, complaints, and any scenario that falls outside approved administrative rules. AI should not diagnose, triage clinical symptoms, advise on treatment, or make promises about coverage or appointment availability. The system should route these cases to the group’s approved process.
Leadership should also require a clear vendor and security review. Confirm the data-flow boundaries, access controls, contractual responsibilities, retention practices, integration permissions, incident process, and the evidence available for ongoing oversight. HHS guidance on privacy, security, and HIPAA is a useful starting point for understanding why healthcare technology decisions require deliberate safeguards. It does not replace the group’s own legal, privacy, or security review.
Quality assurance should be designed before the tool starts handling production work. Review a defined sample of outputs, compare them with the approved workflow, log failure patterns, and set a threshold that triggers correction or suspension. The QA process needs to look across locations so a recurring issue is not dismissed as an isolated site problem. The principles in front-office standardization for optometry groups apply here: the workflow, training, and quality criteria must share the same source of truth.
Should You Buy Software, Build Internally, or Use a Managed Partner?
The choice is not simply between buying an AI product and doing nothing. Most groups have three broad models: purchase a tool and operate it internally, build or configure a solution with internal technical ownership, or use a managed partner that incorporates technology into a defined service model.
Buying software can fit when the group has stable workflows, internal operations ownership, integration capacity, and enough volume to justify the management effort. It gives leadership direct control, but it also leaves the group responsible for configuration, training, monitoring, and improvement.
Building internally can make sense when the workflow is strategically distinctive and the organization has the technical, security, and operating capacity to maintain it. It carries the greatest ongoing commitment. A custom tool is not finished when it launches. It needs controls, documentation, tests, support, and change management as locations and systems evolve.
A managed partner can be a better fit when the immediate problem is dependable execution of recurring administrative work rather than ownership of a new technology layer. The group should still retain ownership of its workflow standards, permissions, escalation rules, and quality expectations. A partner can provide staffing and operational depth, but it should not become the unexamined source of policy. The broader comparison in healthcare call-center outsourcing for multi-location groups can help executives assess that boundary.
How Should a Group Pilot AI Without Disrupting Access?
Run a narrow, reversible pilot. Select one request type or a limited group of locations, keep the existing process available, and define the specific workflow change. Avoid a launch that changes intake, scheduling, recall, reporting, and staffing at the same time. When several variables move together, leadership cannot tell what caused the result.
Before launch, record the baseline, document the approved workflow, train the people who will monitor exceptions, and tell participating locations what the pilot does and does not change. During the pilot, review queue activity and a sample of completed work at a regular cadence. Look for incomplete records, inappropriate routing, repeat callbacks, staff workarounds, patient confusion, and differences between locations.
The pilot should have explicit decision criteria. Expand only if the tool meets the defined quality and operational thresholds without creating unacceptable risk or manual burden. Revise if the issue is fixable through workflow or configuration. Stop if the tool cannot operate within the group’s requirements. This is a more useful test than asking whether staff “like AI.”
An effective pilot also creates reusable operating knowledge. Every exception should either reinforce an existing rule, expose a missing one, or show that the use case is not ready for automation. That feedback improves the underlying patient-access system whether the group expands the tool or not.
What Is the Right Decision Framework for Executives?
AI investment is worthwhile when the group can identify a repeatable workflow, establish a baseline, protect patient-access quality, and assign an accountable owner for the change. The objective is not to appear technologically advanced. It is to create a more reliable operating system for patients, locations, and leadership.
The practical sequence is straightforward: standardize the process, choose a bounded use case, calculate the total cost, establish governance, pilot with human review, and scale only when the evidence supports it. If a group is not ready for direct AI ownership, a managed patient-access model may be a sound interim or long-term choice. The decision should follow the operating problem, not the market noise.
Ready to Improve Your Patient Retention?
MyBCAT helps healthcare practices recapture missed calls and automate patient scheduling so no opportunity slips through the cracks.
